Pulmonary Paragonimiasis (Lung Fluke)

1. Comprehensive Executive Overview

Pulmonary Paragonimiasis (ICD-10: B66.4), commonly referred to as "Lung Fluke disease," is a parasitic infection caused by trematodes of the genus Paragonimus. While there are over 30 species of Paragonimus known to infect humans, Paragonimus westermani is the most clinically significant and widespread globally, particularly in East and Southeast Asia, parts of Africa, and South America.

The infection is classified as a foodborne zoonosis, acquired primarily through the ingestion of raw or undercooked freshwater crustaceans, such as crabs or crayfish, that harbor the encysted metacercariae of the parasite. Once ingested, the larvae migrate through the intestinal wall, penetrate the diaphragm, and enter the pulmonary parenchyma. This migration leads to the formation of cystic cavities, chronic inflammation, and symptoms that frequently mimic pulmonary tuberculosis (TB), often leading to diagnostic delays or misdiagnosis.

Understanding this condition is critical for clinicians in endemic regions and for practitioners evaluating patients with unexplained chronic cough and hemoptysis who have a history of travel or dietary exposure to raw shellfish.

2. Pathophysiology, Etiology, and Risk Factors

Etiology and Transmission

The life cycle of Paragonimus is complex, requiring two intermediate hosts:
1. First Intermediate Host: Freshwater snails.
2. Second Intermediate Host: Freshwater crustaceans (crabs and crayfish).

Humans serve as the definitive host. Upon ingestion of the metacercariae, the larvae excyst in the duodenum, penetrate the intestinal wall, and traverse the peritoneal cavity to reach the diaphragm. They then enter the pleural space and penetrate the lung tissue.

Pathophysiology

The pathology of pulmonary paragonimiasis is driven by the migration of the juvenile flukes and the subsequent host immune response to the adult flukes residing in the lung.
* Initial Migration: Mechanical damage occurs as the larvae migrate through the liver and diaphragm, causing localized inflammation.
* Cyst Formation: Once in the lungs, the flukes usually reside in pairs within fibrous, thick-walled cysts (often 1–2 cm in diameter). These cysts communicate with the bronchial tree, allowing the parasite’s eggs to be coughed up in sputum or swallowed and excreted in feces.
* Inflammatory Response: The presence of eggs in the surrounding lung tissue triggers a granulomatous inflammatory reaction, leading to fibrosis and bronchiectasis.

Risk Factors

• Dietary Habits: Consumption of "drunken crab" (crabs soaked in wine or vinegar) or raw/undercooked crab meat.
• Geographic Exposure: Living in or traveling to endemic regions in Asia, South America, or Africa.
• Traditional Medicine: Use of raw crayfish juice for local traditional remedies in certain cultures.

3. Signs, Symptoms, and Clinical Presentation

The clinical presentation of pulmonary paragonimiasis is often indolent and chronic, which contributes to its reputation as a "great masquerader" of tuberculosis.

Clinical Distinctions

• Hemoptysis: Unlike TB, where hemoptysis is often profuse, the hemoptysis in paragonimiasis is typically characterized by small amounts of blood mixed with brownish or rust-colored sputum, which contains the parasitic eggs.
• Physical Exam: Lung auscultation may reveal localized crackles, wheezing, or signs of pleural effusion. In severe, chronic cases, clinical signs of bronchiectasis may be evident.

4. Standard Diagnostic Evaluation & Workup

Accurate diagnosis is paramount to prevent long-term pulmonary damage. The gold standard remains the demonstration of Paragonimus eggs in biological samples.

Laboratory Assays

1. Sputum Examination: The most direct diagnostic method. Samples should be collected on multiple days. Eggs are found in the sputum or in fecal samples (if the patient swallows the sputum).
2. Serology: Enzyme-linked immunosorbent assay (ELISA) is highly sensitive and is the primary tool for screening in non-endemic areas.
3. Peripheral Blood: Eosinophilia is a hallmark finding in the acute and chronic phases of the disease.

Imaging Modalities

• Chest X-ray (CXR): Findings are non-specific but may show patchy infiltrates, nodules, ring shadows (cysts), or pleural thickening.
• High-Resolution CT (HRCT): The diagnostic imaging of choice. HRCT typically reveals:
  • Cystic lesions with thin or thick walls.
  • Nodular opacities.
  • "Tunnel-like" tracks representing the migration path of the fluke.
  • Pleural effusion or thickening.

Biopsy

If imaging and sputum tests are inconclusive, a lung biopsy (usually via bronchoscopy or video-assisted thoracoscopic surgery - VATS) may be indicated to rule out malignancy or TB, particularly if the radiographic features are atypical.

5. Therapeutic Interventions

The prognosis for pulmonary paragonimiasis is excellent if treated promptly with appropriate anthelmintic therapy.

Pharmacotherapy

• Praziquantel: The drug of choice. The standard regimen is 25 mg/kg administered three times daily for 2 to 3 days. It is highly effective, with cure rates exceeding 90%.
• Triclabendazole: An alternative for patients who cannot tolerate Praziquantel or in cases of treatment failure. The typical dose is 10 mg/kg, usually given in two divided doses.

Surgical Intervention

Surgery is rarely required for pulmonary paragonimiasis. It is reserved for:
* Cases of severe, localized destruction of lung tissue (e.g., massive bronchiectasis).
* Diagnostic uncertainty where malignancy cannot be excluded.
* Complications such as empyema or severe, recurrent hemoptysis that is unresponsive to medical management.

Lifestyle and Follow-up

• Dietary Education: Strict avoidance of raw or undercooked freshwater crustaceans is the most effective preventative measure.
• Follow-up: Patients should undergo repeat sputum examinations or serology 3–6 months post-treatment to confirm the eradication of the parasite.

6. Frequently Asked Questions (FAQ)

1. Is pulmonary paragonimiasis contagious?
No, it is not spread from person to person. You must ingest the metacercariae from an infected intermediate host (crabs/crayfish).

2. Can this condition be mistaken for tuberculosis?
Yes. Because both cause chronic cough, hemoptysis, and similar chest X-ray findings, it is frequently misdiagnosed as pulmonary TB.

3. Is the disease fatal?
Pulmonary paragonimiasis is rarely fatal if treated. However, if untreated, it can lead to chronic pulmonary insufficiency, bronchiectasis, or extrapulmonary migration (e.g., cerebral paragonimiasis).

4. How long does the treatment take?
The standard course of Praziquantel is very short, typically lasting only 2 to 3 days.

5. Are there any side effects of Praziquantel?
Common side effects include headache, dizziness, abdominal pain, and nausea, which are usually transient.

6. Can I get this from eating cooked crabs?
Thorough cooking (boiling, steaming, or frying) kills the parasite. The risk comes specifically from raw or improperly processed (marinated/pickled) shellfish.

7. Does the infection go away on its own?
While the flukes have a limited lifespan (often 5–10 years), the resulting lung damage, fibrosis, and chronic inflammation persist, making medical treatment necessary.

8. Is blood testing enough for a diagnosis?
Serology (blood tests) is excellent for screening, but definitive diagnosis usually requires finding the eggs in sputum or stool.

9. What happens if the parasite migrates to the brain?
Cerebral paragonimiasis is a rare but serious complication causing seizures, headaches, and visual disturbances. It requires more aggressive treatment and monitoring.

10. How soon after eating infected food do symptoms appear?
The incubation period varies, typically ranging from 2 to 15 weeks after ingestion.